Change Language

Select Language

COVID-19
The pandemic continues to cause unprecedented disruption across industries worldwide.
Get detailed insights regarding the impact of COVID-19 on the market.

Glycomics Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027

Market Overview:

The global glycomics market reached a value of US$ 1.21 Billion in 2021. Looking forward, IMARC Group expects the market to reach a value of US$ 2.52 Billion by 2027, exhibiting a CAGR of 12.80% during 2022-2027. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.

Glycomics refers to a study that aids in defining or quantifying the glycome of a cell, tissue, or organism. It mainly assists in identifying the structure and function of the complete set of glycans produced in a single organism and determining all the genes that encode glycoproteins. It also aids in establishing the role of carbohydrate-protein interactions in cell-cell communication. As a result, glycomics finds extensive application in diagnostics, drug discovery, and immunology across the globe.

Glycomics Market Trends:

Presently, there is a rise in the prevalence of chronic diseases on account of sedentary lifestyles and the growing number of individuals who smoke and consume alcohol. In line with this, the coronavirus disease (COVID-19) outbreak has positively influenced the demand for vaccine and treatment drugs to prevent the spread of the pandemic worldwide. This, in turn, is strengthening the growth of the glycomics market. Besides this, glycomics is gaining preference for training and educational purposes around the world. This, in confluence with its extensive applicability in research centers due to the increasing adoption of glycan structure data analysis, is contributing to market growth. Furthermore, leading market players are continuously funding research and development (R&D) activities to enhance the ability of structurally complex glycans to be employed as therapeutics. Consequently, they are developing advanced technologies, such as high-performance liquid chromatography (HPLC), mass spectrometry (MS), and capillary electrophoresis (CE) in chemical and biochemical research. Moreover, a growing number of Contract Research Organizations (CROs) for the development and production of drugs and biologics is driving the market. Some of the other factors, such as the thriving pharmaceutical industry, rising number of clinical trials, and the improving healthcare infrastructure, are anticipated to propel the market growth.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global glycomics market, along with forecasts at the global, regional and country level from 2022-2027. Our report has categorized the market based on product, application and end user.

Breakup by Product:

  • Enzymes
    • Glycosidases
    • Glycosyltransferases
    • Neuraminidases
    • Sialyltransferases
    • Others
  • Instruments
    • Mass Spectrometers
    • HPLC 
    • MALDI-TOF
    • Array systems
    • Others
  • Kits
    • Glycan Labeling Kits
    • Glycan Purification Kits
    • Glycan Release Kits
    • Others
  • Reagents
    • Glycoproteins
    • Monosaccharides
    • Oligosaccharides
    • Others
       

Breakup by Application:

  • Drug Discovery and Development
  • Diagnostics
  • Others
     

Breakup by End User:

  • Academic and Research Institutes
  • Pharmaceutical and Biotechnology Companies
  • Contract Research Organizations (CROs)
     

Breakup by Region:

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East and Africa
     

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Agilent Technologies Inc., Asparia Glycomics, Bruker Corporation, Danaher Corporation, Dextra Laboratories Limited (New Zealand Pharmaceuticals Limited), Merck KGaA, New England Biolabs, RayBiotech Life Inc., Shimadzu Corporation, Takara Bio Inc., Thermo Fisher Scientific Inc. and Waters Corporation.

Report Coverage:

Report Features Details
Base Year of the Analysis 2021
    Historical Period 2016-2021
Forecast Period 2022-2027
Units US$ Billion
Segment Coverage Product, Application, End User, Region
Region Covered  Asia Pacific, Europe, North America, Latin America, Middle East and Africa
Countries Covered United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico
Companies Covered Agilent Technologies Inc., Asparia Glycomics, Bruker Corporation, Danaher Corporation, Dextra Laboratories Limited (New Zealand Pharmaceuticals Limited), Merck KGaA, New England Biolabs, RayBiotech Life Inc., Shimadzu Corporation, Takara Bio Inc., Thermo Fisher Scientific Inc. and Waters Corporation.
Customization Scope 10% Free Customization
Report Price and Purchase Option Single User License: US$ 2499
Five User License: US$ 3499
Corporate License: US$ 4499
Post-Sale Analyst Support 10-12 Weeks
Delivery Format PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)

1    Preface
2    Scope and Methodology

    2.1    Objectives of the Study
    2.2    Stakeholders
    2.3    Data Sources
        2.3.1    Primary Sources
        2.3.2    Secondary Sources
    2.4    Market Estimation
        2.4.1    Bottom-Up Approach
        2.4.2    Top-Down Approach
    2.5    Forecasting Methodology
3    Executive Summary
4    Introduction

    4.1    Overview
    4.2    Key Industry Trends
5    Global Glycomics Market
    5.1    Market Overview
    5.2    Market Performance
    5.3    Impact of COVID-19
    5.4    Market Forecast
6    Market Breakup by Product
    6.1    Enzymes
        6.1.1 Market Trends
        6.1.2 Key Segments
           6.1.2.1 Glycosidases
           6.1.2.2 Glycosyltransferases
           6.1.2.3 Neuraminidases
           6.1.2.4 Sialyltransferases
           6.1.2.5 Others
        6.1.3 Market Forecast
    6.2    Instruments
        6.2.1 Market Trends
        6.2.2 Key Segments
           6.2.2.1 Mass Spectrometers
           6.2.2.2 HPLC 
           6.2.2.3 MALDI-TOF
           6.2.2.4 Array systems
           6.2.2.5 Others
        6.2.3 Market Forecast
    6.3    Kits
        6.3.1 Market Trends
        6.3.2 Key Segments
           6.3.2.1 Glycan Labeling Kits
           6.3.2.2 Glycan Purification Kits
           6.3.2.3 Glycan Release Kits
           6.3.2.4 Others
        6.3.3 Market Forecast
    6.4    Reagents
        6.4.1 Market Trends
        6.4.2 Key Segments
           6.4.2.1 Glycoproteins
           6.4.2.2 Monosaccharides
           6.4.2.3 Oligosaccharides
           6.4.2.4 Others
        6.4.3 Market Forecast
7    Market Breakup by Application
    7.1    Drug Discovery and Development
        7.1.1 Market Trends
        7.1.2 Market Forecast
    7.2    Diagnostics
        7.2.1 Market Trends
        7.2.2 Market Forecast
    7.3    Others
        7.3.1 Market Trends
        7.3.2 Market Forecast
8    Market Breakup by End User
    8.1    Academic and Research Institutes
        8.1.1 Market Trends
        8.1.2 Market Forecast
    8.2    Pharmaceutical and Biotechnology Companies
        8.2.1 Market Trends
        8.2.2 Market Forecast
    8.3    Contract Research Organizations (CROs)
        8.3.1 Market Trends
        8.3.2 Market Forecast
9    Market Breakup by Region
    9.1    North America
        9.1.1 United States
           9.1.1.1 Market Trends
           9.1.1.2 Market Forecast
        9.1.2 Canada
           9.1.2.1 Market Trends
           9.1.2.2 Market Forecast
    9.2    Asia-Pacific
        9.2.1 China
           9.2.1.1 Market Trends
           9.2.1.2 Market Forecast
        9.2.2 Japan
           9.2.2.1 Market Trends
           9.2.2.2 Market Forecast
        9.2.3 India
           9.2.3.1 Market Trends
           9.2.3.2 Market Forecast
        9.2.4 South Korea
           9.2.4.1 Market Trends
           9.2.4.2 Market Forecast
        9.2.5 Australia
           9.2.5.1 Market Trends
           9.2.5.2 Market Forecast
        9.2.6 Indonesia
           9.2.6.1 Market Trends
           9.2.6.2 Market Forecast
        9.2.7 Others
           9.2.7.1 Market Trends
           9.2.7.2 Market Forecast
    9.3    Europe
        9.3.1 Germany
           9.3.1.1 Market Trends
           9.3.1.2 Market Forecast
        9.3.2 France
           9.3.2.1 Market Trends
           9.3.2.2 Market Forecast
        9.3.3 United Kingdom
           9.3.3.1 Market Trends
           9.3.3.2 Market Forecast
        9.3.4 Italy
           9.3.4.1 Market Trends
           9.3.4.2 Market Forecast
        9.3.5 Spain
           9.3.5.1 Market Trends
           9.3.5.2 Market Forecast
        9.3.6 Russia
           9.3.6.1 Market Trends
           9.3.6.2 Market Forecast
        9.3.7 Others
           9.3.7.1 Market Trends
           9.3.7.2 Market Forecast
    9.4    Latin America
        9.4.1 Brazil
           9.4.1.1 Market Trends
           9.4.1.2 Market Forecast
        9.4.2 Mexico
           9.4.2.1 Market Trends
           9.4.2.2 Market Forecast
        9.4.3 Others
           9.4.3.1 Market Trends
           9.4.3.2 Market Forecast
    9.5    Middle East and Africa
        9.5.1 Market Trends
        9.5.2 Market Breakup by Country
        9.5.3 Market Forecast
10    SWOT Analysis
    10.1    Overview
    10.2    Strengths
    10.3    Weaknesses
    10.4    Opportunities
    10.5    Threats
11    Value Chain Analysis
12    Porters Five Forces Analysis

    12.1    Overview
    12.2    Bargaining Power of Buyers
    12.3    Bargaining Power of Suppliers
    12.4    Degree of Competition
    12.5    Threat of New Entrants
    12.6    Threat of Substitutes
13    Price Analysis
14    Competitive Landscape

    14.1    Market Structure
    14.2    Key Players
    14.3    Profiles of Key Players
        14.3.1    Agilent Technologies Inc.
           14.3.1.1 Company Overview
           14.3.1.2 Product Portfolio
           14.3.1.3 Financials
           14.3.1.4 SWOT Analysis
        14.3.2    Asparia Glycomics
           14.3.2.1 Company Overview
           14.3.2.2 Product Portfolio
        14.3.3    Bruker Corporation
           14.3.3.1 Company Overview
           14.3.3.2 Product Portfolio
           14.3.3.3 Financials
           14.3.3.4 SWOT Analysis
        14.3.4    Danaher Corporation
           14.3.4.1 Company Overview
           14.3.4.2 Product Portfolio
           14.3.4.3 Financials
           14.3.4.4 SWOT Analysis
        14.3.5    Dextra Laboratories Limited (New Zealand Pharmaceuticals Limited)
           14.3.5.1 Company Overview
           14.3.5.2 Product Portfolio
        14.3.6    Merck KGaA
           14.3.6.1 Company Overview
           14.3.6.2 Product Portfolio
           14.3.6.3 Financials
           14.3.6.4 SWOT Analysis
        14.3.7    New England Biolabs
           14.3.7.1 Company Overview
           14.3.7.2 Product Portfolio
        14.3.8    RayBiotech Life Inc.
           14.3.8.1 Company Overview
           14.3.8.2 Product Portfolio
        14.3.9    Shimadzu Corporation
           14.3.9.1 Company Overview
           14.3.9.2 Product Portfolio
           14.3.9.3 Financials
           14.3.9.4 SWOT Analysis
        14.3.10    Takara Bio Inc.
           14.3.10.1 Company Overview
           14.3.10.2 Product Portfolio
           14.3.10.3 Financials
        14.3.11    Thermo Fisher Scientific Inc.
           14.3.11.1 Company Overview
           14.3.11.2 Product Portfolio
           14.3.11.3 Financials
           14.3.11.4 SWOT Analysis
        14.3.12    Waters Corporation
           14.3.12.1 Company Overview
           14.3.12.2 Product Portfolio
           14.3.12.3 Financials
           14.3.12.4 SWOT Analysis

List of Figures

Figure 1: Global: Glycomics Market: Major Drivers and Challenges
Figure 2: Global: Glycomics Market: Sales Value (in Billion US$), 2016-2021
Figure 3: Global: Glycomics Market Forecast: Sales Value (in Billion US$), 2022-2027
Figure 4: Global: Glycomics Market: Breakup by Product (in %), 2021
Figure 5: Global: Glycomics Market: Breakup by Application (in %), 2021
Figure 6: Global: Glycomics Market: Breakup by End User (in %), 2021
Figure 7: Global: Glycomics Market: Breakup by Region (in %), 2021
Figure 8: Global: Glycomics (Enzymes) Market: Sales Value (in Million US$), 2016 & 2021
Figure 9: Global: Glycomics (Enzymes) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 10: Global: Glycomics (Instruments) Market: Sales Value (in Million US$), 2016 & 2021
Figure 11: Global: Glycomics (Instruments) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 12: Global: Glycomics (Kits) Market: Sales Value (in Million US$), 2016 & 2021
Figure 13: Global: Glycomics (Kits) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 14: Global: Glycomics (Reagents) Market: Sales Value (in Million US$), 2016 & 2021
Figure 15: Global: Glycomics (Reagents) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 16: Global: Glycomics (Drug Discovery and Development) Market: Sales Value (in Million US$), 2016 & 2021
Figure 17: Global: Glycomics (Drug Discovery and Development) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 18: Global: Glycomics (Diagnostics) Market: Sales Value (in Million US$), 2016 & 2021
Figure 19: Global: Glycomics (Diagnostics) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 20: Global: Glycomics (Other Applications) Market: Sales Value (in Million US$), 2016 & 2021
Figure 21: Global: Glycomics (Other Applications) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 22: Global: Glycomics (Academic and Research Institutes) Market: Sales Value (in Million US$), 2016 & 2021
Figure 23: Global: Glycomics (Academic and Research Institutes) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 24: Global: Glycomics (Pharmaceutical and Biotechnology Companies) Market: Sales Value (in Million US$), 2016 & 2021
Figure 25: Global: Glycomics (Pharmaceutical and Biotechnology Companies) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 26: Global: Glycomics (Contract Research Organizations-CROs) Market: Sales Value (in Million US$), 2016 & 2021
Figure 27: Global: Glycomics (Contract Research Organizations-CROs) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 28: North America: Glycomics Market: Sales Value (in Million US$), 2016 & 2021
Figure 29: North America: Glycomics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 30: United States: Glycomics Market: Sales Value (in Million US$), 2016 & 2021
Figure 31: United States: Glycomics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 32: Canada: Glycomics Market: Sales Value (in Million US$), 2016 & 2021
Figure 33: Canada: Glycomics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 34: Asia-Pacific: Glycomics Market: Sales Value (in Million US$), 2016 & 2021
Figure 35: Asia-Pacific: Glycomics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 36: China: Glycomics Market: Sales Value (in Million US$), 2016 & 2021
Figure 37: China: Glycomics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 38: Japan: Glycomics Market: Sales Value (in Million US$), 2016 & 2021
Figure 39: Japan: Glycomics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 40: India: Glycomics Market: Sales Value (in Million US$), 2016 & 2021
Figure 41: India: Glycomics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 42: South Korea: Glycomics Market: Sales Value (in Million US$), 2016 & 2021
Figure 43: South Korea: Glycomics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 44: Australia: Glycomics Market: Sales Value (in Million US$), 2016 & 2021
Figure 45: Australia: Glycomics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 46: Indonesia: Glycomics Market: Sales Value (in Million US$), 2016 & 2021
Figure 47: Indonesia: Glycomics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 48: Others: Glycomics Market: Sales Value (in Million US$), 2016 & 2021
Figure 49: Others: Glycomics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 50: Europe: Glycomics Market: Sales Value (in Million US$), 2016 & 2021
Figure 51: Europe: Glycomics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 52: Germany: Glycomics Market: Sales Value (in Million US$), 2016 & 2021
Figure 53: Germany: Glycomics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 54: France: Glycomics Market: Sales Value (in Million US$), 2016 & 2021
Figure 55: France: Glycomics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 56: United Kingdom: Glycomics Market: Sales Value (in Million US$), 2016 & 2021
Figure 57: United Kingdom: Glycomics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 58: Italy: Glycomics Market: Sales Value (in Million US$), 2016 & 2021
Figure 59: Italy: Glycomics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 60: Spain: Glycomics Market: Sales Value (in Million US$), 2016 & 2021
Figure 61: Spain: Glycomics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 62: Russia: Glycomics Market: Sales Value (in Million US$), 2016 & 2021
Figure 63: Russia: Glycomics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 64: Others: Glycomics Market: Sales Value (in Million US$), 2016 & 2021
Figure 65: Others: Glycomics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 66: Latin America: Glycomics Market: Sales Value (in Million US$), 2016 & 2021
Figure 67: Latin America: Glycomics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 68: Brazil: Glycomics Market: Sales Value (in Million US$), 2016 & 2021
Figure 69: Brazil: Glycomics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 70: Mexico: Glycomics Market: Sales Value (in Million US$), 2016 & 2021
Figure 71: Mexico: Glycomics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 72: Others: Glycomics Market: Sales Value (in Million US$), 2016 & 2021
Figure 73: Others: Glycomics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 74: Middle East and Africa: Glycomics Market: Sales Value (in Million US$), 2016 & 2021
Figure 75: Middle East and Africa: Glycomics Market: Breakup by Country (in %), 2021
Figure 76: Middle East and Africa: Glycomics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 77: Global: Glycomics Industry: SWOT Analysis
Figure 78: Global: Glycomics Industry: Value Chain Analysis
Figure 79: Global: Glycomics Industry: Porter's Five Forces Analysis

List of Tables

Table 1: Global: Glycomics Market: Key Industry Highlights, 2021 and 2027
Table 2: Global: Glycomics Market Forecast: Breakup by Product (in Million US$), 2022-2027
Table 3: Global: Glycomics Market Forecast: Breakup by Application (in Million US$), 2022-2027
Table 4: Global: Glycomics Market Forecast: Breakup by End User (in Million US$), 2022-2027
Table 5: Global: Glycomics Market Forecast: Breakup by Region (in Million US$), 2022-2027
Table 6: Global: Glycomics Market: Competitive Structure
Table 7: Global: Glycomics Market: Key Players


Note: We value your privacy and will never rent or sell your email address. Privacy policy

Key Questions Answered in This Report

The global glycomics market was valued at US$ 1.21 Billion in 2021.

We expect the global glycomics market to exhibit a CAGR of 12.80% during 2022-2027.

The high prevalence of several chronic diseases, growing number of clinical trials, and increasing
demand for glycomics for training and educational purposes, are primarily driving the global glycomics
market.

The sudden outbreak of the COVID-19 pandemic has led to the rising demand for glycomics across
several nations for vaccine production to prevent the spread of the coronavirus infection.

Based on the product, the global glycomics market can be segmented into enzymes, instruments, kits,
and reagents. Currently, enzymes hold the majority of the total market share.

Based on the application, the global glycomics market has been divided into drug discovery and
development, diagnostics, and others. Among these, drug discovery and development segment
currently exhibits a clear dominance in the market.

Based on the end user, the global glycomics market can be categorized into academic and research
institutes, pharmaceutical and biotechnology companies, and Contract Research Organizations (CROs).
Currently, academic and research institutes account for the largest market share.

On a regional level, the market has been classified into North America, Asia-Pacific, Europe, Latin
America, and Middle East and Africa, where North America currently dominates the global market.

Some of the major players in the global glycomics market include Agilent Technologies Inc., Asparia
Glycomics, Bruker Corporation, Danaher Corporation, Dextra Laboratories Limited (New Zealand
Pharmaceuticals Limited), Merck KGaA, New England Biolabs, RayBiotech Life Inc., Shimadzu
Corporation, Takara Bio Inc., Thermo Fisher Scientific Inc., and Waters Corporation.

Need more help?

  •   Speak to our experienced analysts for insights on the current market scenarios.
  •   Include additional segments and countries to customize the report as per your requirement.
  •   Gain an unparalleled competitive advantage in your domain by understanding how to utilize the report and positively impacting your operations and revenue.
  •   For further assistance, please connect with our analysts.

Purchase Options




$ 2499

REACH OUT TO US

Call us on

( US: +1-631-791-1145 )
( UK: +44-753-713-2163 )
( India: +91 120 433 0800 )


Drop us an email at

sales@imarcgroup.com

Social Links

4